Background Safe and effective long-acting injectable agents for preexposure prophylaxis (PrEP)
for human immunodeficiency virus (HIV) infection are needed to increase the options …

Importance New data and therapeutic options warrant updated recommendations for the
use of antiretroviral drugs (ARVs) to treat or to prevent HIV infection in adults. Objective To …

Importance Recent advances in treatment and prevention of HIV warrant updated
recommendations to guide optimal practice. Objective Based on a critical evaluation of new data, to …

Importance Antiretroviral therapy (ART) is the cornerstone of prevention and management
of HIV infection. Objective To evaluate new data and treatments and incorporate this …

Importance Data on the use of antiretroviral drugs, including new drugs and formulations, for
the treatment and prevention of HIV infection continue to guide optimal practices. Objective …

Young men who have sex with men (YMSM) are at alarming risk for HIV acquisition,
demonstrating the highest rates of incident infection of any age-risk group. GRINDR is a global …

This article has been corrected. The original version (PDF) is appended to this article as a
Supplement . Background: Nonnucleoside reverse transcriptase inhibitor–based antiretroviral …

The objective of this mixed methods study was to examine current sexual risk behaviors,
acceptability and potential adoption of pre-exposure prophylaxis (PrEP) for HIV prevention, and …

Importance Adolescents represent a key population for implementing preexposure
prophylaxis (PrEP) interventions worldwide, yet tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) …

The development of antiretroviral therapy for the prevention and treatment of HIV infection
has been marked by a series of remarkable successes. However, the efforts to develop a …